STERIS plc (STE) Financials

STE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2025 10.1 billion 3.5 billion
Dec. 31, 2024 10.0 billion 3.6 billion
Sept. 30, 2024 10.2 billion 3.6 billion
June 30, 2024 10.1 billion 3.7 billion

STE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 ? ?
Dec. 31, 2024 243.6 million 15.3 million
Sept. 30, 2024 148.8 million 20.8 million
June 30, 2024 195.7 million 11.5 million

STE Net Income
Graph available only for supporters. Become a supporter to see it.
DateNet Income
March 31, 2025 ?
Dec. 31, 2024 173.3 million
Sept. 30, 2024 151.2 million
June 30, 2024 145.5 million

STE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2025 171.7 million - -
Dec. 31, 2024 155.2 million 2.2 billion 156.2 million
Sept. 30, 2024 172.2 million 2.3 billion 163.7 million
June 30, 2024 198.3 million 2.4 billion 169.1 million

STE Shares Outstanding
Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2025 ?
Dec. 31, 2024 98.9 million
Sept. 30, 2024 99.2 million
June 30, 2024 99.4 million

STE Expenses
Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2025 - 27.7 million 333.9 million -
Dec. 31, 2024 89.2 million 27.4 million 335.5 million -
Sept. 30, 2024 101.9 million 27.0 million 329.3 million -
June 30, 2024 108.1 million 25.6 million 305.2 million -

STE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2025 1.5 billion 839.3 million
Dec. 31, 2024 1.4 billion 760.2 million
Sept. 30, 2024 1.3 billion 750.1 million
June 30, 2024 1.3 billion 706.8 million

STE Revenue by Segment
Graph available only for supporters. Become a supporter to see it.

STE

List: Contenders

Price: $226.97

52 week price:
200.98
252.79

Dividend Yield: 0.90%

5-year range yield:
0.76%
1.07%

Forward Dividend Yield: 1.00%

Payout Ratio: 40.28%

Payout Ratio Range:
-3732.53%
800.00%

Dividend Per Share: 2.28 USD

Earnings Per Share: 6.16 USD

P/E Ratio: 38.56

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 489871

Ebitda: 149.1 million

Market Capitalization: 23.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 21

DGR3: 9.15%

DGR5: 8.87%

DGR10: 9.50%

Links: